Commonwealth Financial Services
NTLA icon

Commonwealth Financial Services’s Intellia Therapeutics NTLA Stock Holding History

Commonwealth Financial Services’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$128K Sell
10,576
-751
-7% -$9.39K 0.02% 278
2026
Q2 		$192K Buy
+11,327
New +$159K 0.03% 295

Other funds holding NTLA

Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Canal Insurance Company
Canal Insurance Company Greenville, South Carolina $426M AUM 30.47% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Elmwood Wealth Management
Elmwood Wealth Management Berkeley, California $416M AUM 11.87% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
SteelPeak Wealth
SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return
Cyndeo Wealth Partners
Cyndeo Wealth Partners St. Petersburg, Florida $2.21B AUM 17.29% 1-Year Est. Return

Commonwealth Financial Services's NTLA Position: Q3 2026 in Review

Commonwealth Financial Services reduced its Intellia Therapeutics (NTLA) stake by 6.6% in Q3 2026, selling an estimated $9.39K and leaving 10,576 shares worth $128K. The position accounts for 0.02% of the portfolio, ranked #278.

Commonwealth Financial Services first reported a position in NTLA in Q2 2026 and has held it in 2 quarters since. The position peaked at $192K in Q2 2026. 57 funds tracked by Wall St. Rank hold NTLA as of Q3 2026.

  • Commonwealth Financial Services held 10,576 shares of Intellia Therapeutics worth $128K as of Q3 2026.
  • Commonwealth Financial Services sold 751 Intellia Therapeutics shares in Q3 2026, an estimated $9.39K.
  • Intellia Therapeutics made up 0.02% of Commonwealth Financial Services's portfolio in Q3 2026, its #278 holding.
  • Commonwealth Financial Services first reported a position in Intellia Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Commonwealth Financial Services's Intellia Therapeutics position peaked at $192K in Q2 2026.
  • 57 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2026.

Based on Commonwealth Financial Services's 13F filing for Q3 2026, filed 20 Oct 2026.